Slayton William B, Wainman David A, Li Xiao Miao, Hu Zhongbo, Jotwani Anil, Cogle Christopher R, Walker Danielle, Fisher Robert C, Wingard John R, Scott Edward W, Sola Martha C
University of Florida Department of Pediatrics, Gainesville, Florida 32610, USA.
Stem Cells. 2005 Oct;23(9):1400-8. doi: 10.1634/stemcells.2004-0373.
Historically, physicians have attributed delayed platelet engraftment following umbilical cord blood transplant to decreased numbers of stem cells in cord blood compared with adult bone marrow. However, recent studies suggest that delayed platelet engraftment may be caused by an intrinsic inability of neonatal stem cells to produce mature, polyploid megakaryocytes. We tested this hypothesis by transplanting adult bone marrow and newborn liver hematopoietic stem and progenitor cells from transgenic mice expressing green fluorescent protein into myeloablated wild-type recipients and comparing the size and ploidy levels of megakaryocytes that developed in adult transplant recipients. Transplanted stem and progenitor cells, regardless of their source, gave rise to megakaryocytes that were larger than normal adult megakaryocytes as early as 7 days post-transplant. However, megakaryocytes that developed after transplant of neonatal stem and progenitor cells were significantly smaller than those derived from adult stem and progenitor cells. Furthermore, megakaryocytes derived from neonatal cells had lower ploidy values than megakaryocytes derived from adult cells at 18 days post-transplant, when ploidy could first be reliably measured in the bone marrow. These differences in size and ploidy disappeared by 1 month post-transplant. The largest megakaryocytes developed in the spleen. These results suggest that, in the mouse, the microenvironment is responsible for some of the maturational differences in size and ploidy between neonatal and adult megakaryocytes. Furthermore, neonatal and adult megakaryocyte progenitors also have cell-intrinsic differences in the way they engraft and respond to thrombocytopenic stress. These differences may contribute to the delay in platelet engraftment that frequently complicates cord blood transplants.
从历史上看,医生们一直将脐带血移植后血小板植入延迟归因于与成人骨髓相比,脐带血中干细胞数量减少。然而,最近的研究表明,血小板植入延迟可能是由于新生儿干细胞内在无法产生成熟的多倍体巨核细胞所致。我们通过将表达绿色荧光蛋白的转基因小鼠的成人骨髓和新生肝脏造血干细胞及祖细胞移植到经骨髓消融的野生型受体中,并比较成年移植受体中发育的巨核细胞的大小和倍性水平,来验证这一假设。移植的干细胞及祖细胞,无论其来源如何,早在移植后7天就会产生比正常成年巨核细胞更大的巨核细胞。然而,新生儿干细胞及祖细胞移植后发育的巨核细胞明显小于成年干细胞及祖细胞衍生的巨核细胞。此外,在移植后18天,当骨髓中倍性首次能够可靠测量时,来自新生儿细胞的巨核细胞的倍性值低于来自成年细胞的巨核细胞。这些大小和倍性的差异在移植后1个月消失。最大的巨核细胞在脾脏中发育。这些结果表明,在小鼠中,微环境是新生儿和成年巨核细胞在大小和倍性方面一些成熟差异的原因。此外,新生儿和成年巨核细胞祖细胞在植入方式和对血小板减少应激的反应方面也存在细胞内在差异。这些差异可能导致经常使脐带血移植复杂化的血小板植入延迟。